Singapore markets closed

InMode Ltd. (INMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
27.52-1.25 (-4.34%)
At close: 04:00PM EDT
27.96 +0.44 (+1.60%)
After hours: 07:08PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close28.77
Bid27.11 x 900
Ask28.00 x 1300
Day's range26.83 - 28.33
52-week range20.60 - 99.27
Avg. volume1,718,042
Market cap2.286B
Beta (5Y monthly)2.31
PE ratio (TTM)15.29
EPS (TTM)1.80
Earnings date24 Oct 2022 - 28 Oct 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est51.00
  • Motley Fool

    3 Highly Profitable Stocks That Are Super Cheap Right Now

    Bear markets are never fun. Keeping with this theme, the 2022 bear market has created a slew of attractive buying opportunities. Cosmetic surgery company InMode (NASDAQ: INMD),  Swiss pharma giant Novartis (NYSE: NVS), and diabetes care behemoth DexCom (NASDAQ: DXCM) are three highly profitable companies that have been unfairly punished by this irrational market.

  • Motley Fool

    Which Growth Stock Is a Better Buy Right Now -- AbbVie or InMode?

    The popularity of cosmetic procedures is unquestionably on the rise. Major pharmaceutical AbbVie (NYSE: ABBV) is plagued by concerns about the impending patent cliff on its top-selling drug. At the same time, healthcare equipment provider InMode (NASDAQ: INMD) has been punished by Wall Street's current skepticism about growth stocks.

  • Motley Fool

    This Beaten-Down Growth Stock Has Significant Upside Potential. Time to Buy?

    Shareholders of medical technology company InMode (NASDAQ: INMD) have not had a great 2022; the stock has fallen roughly 50% since the beginning of the year. Here are three reasons to consider InMode as a long-term growth stock for your portfolio. InMode designs and builds non-invasive medical equipment for cosmetic procedures like face and body contouring, hair removal, and women's wellness.